{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:07:14Z","timestamp":1791270434966,"version":"4.1.0"},"reference-count":100,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2004,4]]},"abstract":"<jats:p>Much evidence indicates increased sympathetic nervous activity (SNA) in renal disease. Renal ischemia is probably a primary event leading to increased SNA. Increased SNA often occurs in association with hypertension. However, the deleterious effect of increased SNA on the diseased kidney is not only caused by hypertension. Another characteristic of renal disease is unbalanced nitric oxide (NO) and angiotensin (Ang) activity. Increased SNA in renal disease may be sustained because a state of NO\u2013Ang II unbalance is also present in the hypothalamus. Very few studies have directly compared the efficacy of adrenergic blockade with other renoprotective measures. Third-generation \u03b2-blockers seem to have more protective effects than traditional \u03b2-blockers, possibly via stimulation of NO release. Although it has been extensively documented that muscle SNA is increased in chronic renal failure, data on renal SNA and cardiac SNA are not available for these patients before end-stage renal disease. It is also unknown whether additional treatment with third-generation \u03b2-blockers can delay the progression of renal injury and prevent cardiac injury in chronic renal failure more efficiently than conventional treatment with angiotensin-converting enzyme inhibitors only.<\/jats:p>","DOI":"10.1161\/01.hyp.0000121881.77212.b1","type":"journal-article","created":{"date-parts":[[2004,2,24]],"date-time":"2004-02-24T01:55:51Z","timestamp":1077587751000},"page":"699-706","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":138,"title":["Causes and Consequences of Increased Sympathetic Activity in Renal Disease"],"prefix":"10.1161","volume":"43","author":[{"given":"Jaap A.","family":"Joles","sequence":"first","affiliation":[{"name":"From the Department of Nephrology and Hypertension, University Medical Center, Utrecht, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hein A.","family":"Koomans","sequence":"additional","affiliation":[{"name":"From the Department of Nephrology and Hypertension, University Medical Center, Utrecht, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000039578.55705.6E"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000067632.04658.B8"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2000.00360.x"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04728-0"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000069223.98703.8E"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199904293401704"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02663-3"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-0115(03)00116-2"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1997.269"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.29865"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(01)02077-5"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V891437"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V12112427"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000034043.16664.96"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V881232"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91210-X"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.57.5.2996805"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.17.6.1057"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(02)02959-X"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119191"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1992.262.6.E763"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1997.317"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00465.x"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00313.x"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(99)70229-5"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1000742"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199917121-00031"},{"key":"e_1_3_2_28_2","first-page":"S14","volume":"68","year":"1998","unstructured":"Bataineh A, Raij L. Angiotensin II, nitric oxide, and end-organ damage in hypertension. Kidney Int Suppl. 1998; 68: S14\u2013S19.","journal-title":"Kidney Int Suppl"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.0590041458.x"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00542.x"},{"key":"e_1_3_2_31_2","first-page":"H2267","volume":"268","year":"1995","unstructured":"Zanchi A, Schaad NC, Osterheld MC, Grouzmann E, Nussberger J, Brunner HR, Waeber B. Effects of chronic NO synthase inhibition in rats on renin-angiotensin system and sympathetic nervous system. Am J Physiol. 1995; 268: H2267\u2013H2273.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_32_2","first-page":"343","volume":"262","year":"1992","unstructured":"Togashi H, Sakuma I, Yoshioka M, Kobayashi T, Yasuda H, Kitabatake A, Saito H, Gross SS, Levi R. A central nervous system action of nitric oxide in blood pressure regulation. J Pharmacol Exp Ther. 1992; 262: 343\u2013347.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.104.16.1884"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.23.6.971"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1159\/000046020"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00468.2001"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(18)30503-3"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1159\/000188995"},{"key":"e_1_3_2_39_2","first-page":"S138","volume":"55","year":"1996","unstructured":"Tojo A, Kobayashi N, Kimura K, Hirata Y, Matsuoka H, Yagi S, Omata M. Effects of antihypertensive drugs on nitric oxide synthase activity in rat kidney. Kidney Int Suppl. 1996; 55: S138\u2013S140.","journal-title":"Kidney Int Suppl"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.00936.x"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V112283"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.35.3.800"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00218.2002"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.34.1.151"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/15.11.1735"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V1181469"},{"key":"e_1_3_2_47_2","first-page":"948","volume":"279","year":"1996","unstructured":"Barone FC, Nelson AH, Ohlstein EH, Willette RN, Sealey JE, Laragh JH, Campbell WG, Jr., Feuerstein GZ. Chronic carvedilol reduces mortality and renal damage in hypertensive stroke-prone rats. J Pharmacol Erxp The. 1996; 279: 948\u2013955.","journal-title":"J Pharmacol Erxp The"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704329"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000049881.25304.73"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00009.x"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.89.9.815"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000034910.58454.FD"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1161\/atvb.22.3.364"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.2001.280.6.F927"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1997.77.1.75"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00020.2002"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.2001.280.6.F945"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000066912.58385.de"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V12122585"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1159\/000066656"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.059002645.x"},{"key":"e_1_3_2_62_2","first-page":"336","volume":"283","year":"1997","unstructured":"Rodriguez-Perez JC, Losada A, Anabitarte A, Cabrera J, Llobet J, Palop L, Plaza C. Effects of the novel multiple-action agent carvedilol on severe nephrosclerosis in renal ablated rats. J Pharmacol Exp Ther. 1997; 283: 336\u2013344.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1159\/000190295"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1159\/000068529"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1993.tb13610.x"},{"key":"e_1_3_2_66_2","first-page":"293","volume":"3","year":"1995","unstructured":"Erley CM Rebmann S, Strobel U, Schmidt T, Wehrmann M, Osswald H, Risler T. Effects of antihypertensive therapy on blood pressure and renal function in rats with hypertension due to chronic blockade of nitric oxide synthesis. Exp Nephrol. 1995; 3: 293\u2013299.","journal-title":"Exp Nephrol"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.25.433"},{"key":"e_1_3_2_68_2","first-page":"BR378","volume":"8","year":"2002","unstructured":"Wangensteen R, O\u2019Valle F, Del Moral R, Vargas F, Osuna A. Chronic alpha1-adrenergic blockade improves hypertension and renal injury in L-NAME and low-renin L-NAME-DOCA hypertensive rats. Med Sci Monit. 2002; 8: BR378\u2013BR384.","journal-title":"Med Sci Monit"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(00)00594-4"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000035653.72855.bf"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-137-7-200210010-00006"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(03)00241-9"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.36.2.233"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000086521.95630.5a"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00382.x"},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200309000-00021"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200309000-00008"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00265.2002"},{"key":"e_1_3_2_79_2","doi-asserted-by":"publisher","DOI":"10.2337\/diab.42.3.375"},{"key":"e_1_3_2_80_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00578.2002"},{"key":"e_1_3_2_81_2","first-page":"19","volume":"23","year":"1993","unstructured":"Matsuoka H. Protective role of renal nerves in the development of diabetic nephropathy. Diabetes Res. 1993; 23: 19\u201329.","journal-title":"Diabetes Res"},{"key":"e_1_3_2_82_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.27.5.1108"},{"key":"e_1_3_2_83_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V123602"},{"key":"e_1_3_2_84_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1566-0702(02)00295-3"},{"key":"e_1_3_2_85_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/7.9.84S"},{"key":"e_1_3_2_86_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.23.7.888"},{"key":"e_1_3_2_87_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.0590041498.x"},{"key":"e_1_3_2_88_2","first-page":"139","volume":"288","year":"1999","unstructured":"Ernsberger P, Ishizuka T, Liu S, Farrell CJ, Bedol D, Koletsky RJ, Friedman JE. Mechanisms of antihyperglycemic effects of moxonidine in the obese spontaneously hypertensive Kopetzky rat (SHROB). J Pharmacol Exp Ther. 1999; 288: 139\u2013147.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_2_89_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(01)02236-1"},{"key":"e_1_3_2_90_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V75667"},{"key":"e_1_3_2_91_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/5.2.76"},{"key":"e_1_3_2_92_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199816060-00019"},{"key":"e_1_3_2_93_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(00)01231-0"},{"key":"e_1_3_2_94_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000081775.72651.b6"},{"key":"e_1_3_2_95_2","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.2000.2407"},{"key":"e_1_3_2_96_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000065606.63163.b9"},{"key":"e_1_3_2_97_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000091405.00772.6e"},{"key":"e_1_3_2_98_2","doi-asserted-by":"publisher","DOI":"10.1016\/0272-6386(95)90456-5"},{"key":"e_1_3_2_99_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/5.7.437"},{"key":"e_1_3_2_100_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-200202000-00006"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.HYP.0000121881.77212.b1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T16:17:34Z","timestamp":1715530654000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.HYP.0000121881.77212.b1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":100,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["10.1161\/01.HYP.0000121881.77212.b1"],"URL":"https:\/\/doi.org\/10.1161\/01.hyp.0000121881.77212.b1","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4]]},"assertion":[{"value":"2003-10-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-02-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-02-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}